case 4: brca metastatic breast cancer
Published 4 years ago • 176 plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
5:40
case 4: looking forward in brca metastatic tnbc
-
3:46
case 4: parp inhibitors for treating brca triple-negative breast cancer
-
5:38
case 4: olympiad trial for brca metastatic tnbc
-
8:50
case 4: chemotherapy or parp inhibitors for brca tnbc
-
35:13
webinar: new treatment options for metastatic breast cancer
-
3:45
her2 de novo metastatic breast cancer case report
-
3:50
clinical approach to triple-negative breast cancer
-
38:56
robotic surgeries in cancer treatment | kauvery podcast | episode-1| kauvery hospital chennai
-
1:58
discussing targeted treatment with parp inhibitors for brca-mutant patients across tumor types
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
2:30
case review: de novo metastatic er breast cancer
-
4:15
case 2: choosing a cdk4/6 inhibitor in er breast cancer
-
2:15
parp inhibitors in metastatic breast cancer: where are we now?
-
2:42
eribulin as treatment for metastatic breast cancer
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
2:25
metastatic triple negative breast cancer: 2023 best of breast conference
-
1:50
hr breast cancer prognosis
-
3:27
her2 de novo mbc: neratinib vs lapatinib plus capecitabine
-
3:32
sequencing novel her2-targeted therapies in metastatic breast cancer